Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma

This study has been terminated.
(Low enrollment)
Sponsor:
Collaborator:
CLL Topics
Information provided by:
Nevada Cancer Institute
ClinicalTrials.gov Identifier:
NCT00880867
First received: April 10, 2009
Last updated: July 19, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2011
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)